Back in 2018 I wrote an article about the new Libre 2. Finally (as of yesterday) Abbott has got the Libre 2 approved with the TGA for use in Australia. All we know about the rollout and availability of the product is a statement by Abbott that it will be made available “over the coming …
Time In Range (TIR) is one of the popular (and useful!) metrics we get from our CGM data. What percentage of time have we been spending “between the flags” of our defined range. Most CGM reporting software will display this today. For example Dexcom’s Clarity app displays it as a graph, with the traditional “green” …
Dexcom has just announced for Australia another medication which can interfere with their CGMs. Hydroxyurea is a cytotoxic medication used mainly in chemotherapy, so hopefully this won’t affect many people. But it has been shown to artificially raise the readings returned by the Dexcom CGMs (without actually raising the blood glucose). Thus caution should be …
CGM (Continuous Glucose Monitoring) systems are one of today’s most effective tools to help manage diabetes (especially T1D). Thousands of people rely on it to help keep them alive. And yet the costs have just suddenly skyrocketed! The official starting position For a long time AMSL (the distributor of Dexcom CGMs in Australia) had a …
Just to recap the obvious: I use an insulin pump. I also use a CGM. They’re both connected into a closed-loop pump system. But what does that mean? What is a closed loop? Strictly speaking, a “closed loop” is one that operates automatically based on feedback. Often these insulin pump loop systems are referred to …
I’ve been gradually making tweaks to my personal looping/pumping/CGM setup over the last year, and there are some insights to be seen in the graphs that I’d like to point out. Some of the information in this article is stuff I’ve discussed before (last March) but there is some new data here. Especially some insights …